Rocket Pharmaceuticals 2021 Gene Therapy Corporate Presentation

Rocket Pharmaceuticals presents its gene therapy pipeline and clinical development strategy across multiple rare genetic disorders including Fanconi Anemia, Leukocyte Adhesion Deficiency-I, Pyruvate Kinase Deficiency, Infantile Malignant Osteopetrosis, and Danon Disease. The presentation outlines the company's mission centered on trust, generosity, and curiosity in advancing innovative genetic treatments for patients and families.